JP2009531059A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009531059A5 JP2009531059A5 JP2009502327A JP2009502327A JP2009531059A5 JP 2009531059 A5 JP2009531059 A5 JP 2009531059A5 JP 2009502327 A JP2009502327 A JP 2009502327A JP 2009502327 A JP2009502327 A JP 2009502327A JP 2009531059 A5 JP2009531059 A5 JP 2009531059A5
- Authority
- JP
- Japan
- Prior art keywords
- adherent cells
- culture
- placental
- group
- adipose tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 41
- 230000001464 adherent effect Effects 0.000 claims 30
- 210000000577 adipose tissue Anatomy 0.000 claims 15
- 210000005059 placental tissue Anatomy 0.000 claims 15
- 238000000034 method Methods 0.000 claims 9
- 230000003169 placental effect Effects 0.000 claims 9
- 230000001506 immunosuppresive effect Effects 0.000 claims 6
- 239000003550 marker Substances 0.000 claims 6
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 102100022464 5'-nucleotidase Human genes 0.000 claims 3
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 3
- 102100037241 Endoglin Human genes 0.000 claims 3
- 102000006354 HLA-DR Antigens Human genes 0.000 claims 3
- 108010058597 HLA-DR Antigens Proteins 0.000 claims 3
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 3
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims 3
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 3
- 101000881679 Homo sapiens Endoglin Proteins 0.000 claims 3
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 3
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims 3
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims 3
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims 3
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 3
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims 3
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims 3
- 102100022338 Integrin alpha-M Human genes 0.000 claims 3
- 102100025304 Integrin beta-1 Human genes 0.000 claims 3
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims 3
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 3
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims 3
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims 3
- 239000003636 conditioned culture medium Substances 0.000 claims 3
- 238000012258 culturing Methods 0.000 claims 3
- 239000002609 medium Substances 0.000 claims 3
- 201000006417 multiple sclerosis Diseases 0.000 claims 3
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 claims 2
- 102100036630 60S ribosomal protein L7a Human genes 0.000 claims 2
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 claims 2
- 102300038161 CD44 antigen isoform 2 Human genes 0.000 claims 2
- 102000005701 Calcium-Binding Proteins Human genes 0.000 claims 2
- 108010045403 Calcium-Binding Proteins Proteins 0.000 claims 2
- 102100033620 Calponin-1 Human genes 0.000 claims 2
- 101710092112 Calponin-1 Proteins 0.000 claims 2
- 102100031334 Elongation factor 2 Human genes 0.000 claims 2
- 101710139370 Eukaryotic translation elongation factor 2 Proteins 0.000 claims 2
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 2
- 208000035895 Guillain-Barré syndrome Diseases 0.000 claims 2
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 2
- 108010033040 Histones Proteins 0.000 claims 2
- 101150067143 Hnrnph1 gene Proteins 0.000 claims 2
- 101000853243 Homo sapiens 60S ribosomal protein L7a Proteins 0.000 claims 2
- 108090001005 Interleukin-6 Proteins 0.000 claims 2
- 101710177504 Kit ligand Proteins 0.000 claims 2
- 206010049567 Miller Fisher syndrome Diseases 0.000 claims 2
- 101100335081 Mus musculus Flt3 gene Proteins 0.000 claims 2
- 102000001708 Protein Isoforms Human genes 0.000 claims 2
- 108010029485 Protein Isoforms Proteins 0.000 claims 2
- 102000004389 Ribonucleoproteins Human genes 0.000 claims 2
- 108010081734 Ribonucleoproteins Proteins 0.000 claims 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 2
- AGQFLEFSRLZALV-KQYNXXCUSA-N [9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-iminopurin-3-yl]phosphonic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(N(C=NC2=N)P(O)(O)=O)=C2N=C1 AGQFLEFSRLZALV-KQYNXXCUSA-N 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 201000002491 encephalomyelitis Diseases 0.000 claims 2
- 208000024908 graft versus host disease Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000002243 precursor Substances 0.000 claims 2
- 230000003248 secreting effect Effects 0.000 claims 2
- 210000002460 smooth muscle Anatomy 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 238000002054 transplantation Methods 0.000 claims 2
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 208000023328 Basedow disease Diseases 0.000 claims 1
- 208000015023 Graves' disease Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 201000009594 Systemic Scleroderma Diseases 0.000 claims 1
- 206010042953 Systemic sclerosis Diseases 0.000 claims 1
- 230000006052 T cell proliferation Effects 0.000 claims 1
- 208000007502 anemia Diseases 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 206010028417 myasthenia gravis Diseases 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78476906P | 2006-03-23 | 2006-03-23 | |
| US60/784,769 | 2006-03-23 | ||
| US84708806P | 2006-09-26 | 2006-09-26 | |
| US60/847,088 | 2006-09-26 | ||
| PCT/IL2007/000380 WO2007108003A2 (en) | 2006-03-23 | 2007-03-22 | Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011133774A Division JP5766041B2 (ja) | 2006-03-23 | 2011-06-16 | 対象の造血系を増強させるための医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009531059A JP2009531059A (ja) | 2009-09-03 |
| JP2009531059A5 true JP2009531059A5 (https=) | 2010-04-08 |
| JP5733894B2 JP5733894B2 (ja) | 2015-06-10 |
Family
ID=38522837
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009502327A Active JP5733894B2 (ja) | 2006-03-23 | 2007-03-22 | 細胞を拡大培養するための方法ならびに該方法によって作製される細胞および馴化培地の治療のための使用 |
| JP2011133774A Active JP5766041B2 (ja) | 2006-03-23 | 2011-06-16 | 対象の造血系を増強させるための医薬組成物 |
| JP2013263148A Active JP5941454B2 (ja) | 2006-03-23 | 2013-12-20 | 対象の造血系を増強させるための医薬組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011133774A Active JP5766041B2 (ja) | 2006-03-23 | 2011-06-16 | 対象の造血系を増強させるための医薬組成物 |
| JP2013263148A Active JP5941454B2 (ja) | 2006-03-23 | 2013-12-20 | 対象の造血系を増強させるための医薬組成物 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20110129447A1 (https=) |
| EP (5) | EP2548951B1 (https=) |
| JP (3) | JP5733894B2 (https=) |
| KR (2) | KR101557256B1 (https=) |
| CN (1) | CN105296415A (https=) |
| AU (1) | AU2007228341B2 (https=) |
| BR (1) | BRPI0709349A2 (https=) |
| CA (1) | CA2646384C (https=) |
| DK (2) | DK2366775T3 (https=) |
| ES (3) | ES2537641T3 (https=) |
| HK (1) | HK1217513A1 (https=) |
| HR (1) | HRP20160538T1 (https=) |
| HU (1) | HUE028796T2 (https=) |
| IL (1) | IL236213A (https=) |
| MX (1) | MX2008012085A (https=) |
| PL (2) | PL2548951T3 (https=) |
| PT (3) | PT2366775E (https=) |
| RU (1) | RU2433177C2 (https=) |
| SG (1) | SG170761A1 (https=) |
| SI (1) | SI2548951T1 (https=) |
| WO (1) | WO2007108003A2 (https=) |
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2399990B1 (en) | 2003-06-27 | 2015-07-22 | DePuy Synthes Products, Inc. | Cells derived from post-partum umbilical cord for use in treatment of disease of the heart and circulatory system |
| US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
| US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
| US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
| WO2007070870A1 (en) | 2005-12-16 | 2007-06-21 | Ethicon, Inc. | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
| US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
| EP2548951B1 (en) * | 2006-03-23 | 2016-05-04 | Pluristem Ltd. | Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
| CN101611139B (zh) * | 2006-11-13 | 2012-07-04 | 伊西康公司 | 利用微载体的产后来源的细胞的体外扩增 |
| NZ612888A (en) * | 2007-02-12 | 2015-02-27 | Anthrogenesis Corp | Treatment of inflammatory diseases using placental stem cells |
| JP5162784B2 (ja) * | 2007-07-11 | 2013-03-13 | 日東電工株式会社 | 細胞培養基材及びその製造方法並びに細胞培養方法 |
| KR20140107677A (ko) * | 2007-09-19 | 2014-09-04 | 플루리스템 리미티드 | 지방 또는 태반 조직 유래의 부착 세포 및 이의 치료 용도 |
| AU2013267050B2 (en) * | 2007-09-19 | 2016-01-07 | Pluristem Ltd. | Adherent cells from adipose or placenta tissues and use thereof in therapy |
| EP2641606A1 (en) | 2008-05-27 | 2013-09-25 | Pluristem Ltd. | Methods of treating inflammatory colon diseases |
| KR20200011604A (ko) | 2008-08-20 | 2020-02-03 | 안트로제네시스 코포레이션 | 개선된 세포 조성물 및 그의 제조 방법 |
| US20110256108A1 (en) * | 2008-09-02 | 2011-10-20 | Moran Meiron | Methods of selection of cells for transplantation |
| RU2539786C2 (ru) * | 2008-09-02 | 2015-01-27 | Плуристем Лтд. | Выращенные в прикрепленной к субстрату культуре клетки из ткани плаценты и их использование при лечении |
| WO2010026574A2 (en) * | 2008-09-02 | 2010-03-11 | Pluristem Ltd. | Adherent cells from placenta tissue and use thereof in therapy |
| JP5518893B2 (ja) | 2008-12-19 | 2014-06-11 | アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー | 肺ならびに肺の疾患および障害の治療 |
| US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
| EP2411504B1 (en) | 2009-03-26 | 2017-05-10 | DePuy Synthes Products, Inc. | Human umbilical cord tissue cells as therapy for alzheimer's disease |
| CA2781649C (en) * | 2009-11-30 | 2017-07-11 | Pluristem Ltd. | Adherent cells from placenta and use of same in disease treatment |
| US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| EP2575831B1 (en) | 2010-05-27 | 2016-04-20 | Pluristem Ltd. | Skeletal muscle regeneration using mesenchymal stem cells |
| WO2012030968A1 (en) * | 2010-08-31 | 2012-03-08 | Renovocyte, LLC | Systemic, allogenic stem cell therapies for treatment of diseases in animals |
| EP2625264B1 (en) | 2010-10-08 | 2022-12-07 | Terumo BCT, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
| KR101811912B1 (ko) | 2011-03-04 | 2017-12-22 | 아메드 에이치. 알-칸타니 | 스킨 크림 |
| KR101903339B1 (ko) * | 2011-03-22 | 2018-10-01 | 플루리스템 리미티드 | 방사선 또는 화학적 손상을 치료하는 방법 |
| SG10201601537QA (en) | 2011-04-15 | 2016-04-28 | Pluristem Ltd | Methods and systems for harvesting cells |
| US20130142762A1 (en) | 2011-11-07 | 2013-06-06 | Hina W. Chaudhry | Methods of cardiac repair |
| ITTO20111183A1 (it) * | 2011-12-21 | 2013-06-22 | Univ Degli Studi Torino | Mezzo condizionato ottenuto da cellule staminali mesenchimali placentari e suo uso nel trattamento terapeutico della preeclampsia |
| JP6371286B2 (ja) * | 2012-09-04 | 2018-08-08 | プルリステム リミテッド | 子癇前症の予防及び治療方法 |
| EP2902478A1 (en) | 2012-09-06 | 2015-08-05 | Pluristem Ltd. | Devices and methods for culture of cells |
| WO2014128634A1 (en) | 2013-02-20 | 2014-08-28 | Pluristem Ltd. | Gene and protein expression properties of adherent stromal cells cultured in 3d |
| WO2014141111A1 (en) | 2013-03-14 | 2014-09-18 | Pluristem Ltd. | Methods for prevention and treatment of graft-versus-host disease |
| RU2525143C1 (ru) * | 2013-03-22 | 2014-08-10 | Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации-Институт медико-биологических проблем Российской академии наук | СПОСОБ ЭКСПАНСИИ МОНОНУКЛЕАРНЫХ КЛЕТОК ПУПОВИННОЙ КРОВИ (пкМНК) ex vivo В ПРИСУТСТВИИ МУЛЬТИПОТЕНТНЫХ СТРОМАЛЬНЫХ МЕЗЕНХИМАЛЬНЫХ КЛЕТОК (ММСК) |
| RU2539750C2 (ru) * | 2013-04-09 | 2015-01-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Способ оценки иммуносупрессивных свойств мезенхимальных стромальных клеток человека |
| WO2015004609A2 (en) | 2013-07-09 | 2015-01-15 | Pluristem Ltd. | Adherent cells from placenta and use thereof in treatment of injured tendons |
| MX2016001247A (es) | 2013-07-30 | 2016-08-17 | Musculoskeletal Transplant Foundation | Matrices derivadas de tejido suave acelular y metodos para preparar las mismas. |
| WO2015025059A1 (en) * | 2013-08-23 | 2015-02-26 | Fundacion Pública Andaluza Progreso Y Salud | Cd105-negative multipotent mesenchymal stromal cells |
| JP6633522B2 (ja) | 2013-11-16 | 2020-01-22 | テルモ ビーシーティー、インコーポレーテッド | バイオリアクターにおける細胞増殖 |
| EP3114206B1 (en) | 2014-03-04 | 2020-07-29 | Pluristem Ltd. | Systems and methods for growing and harvesting cells |
| WO2015148704A1 (en) | 2014-03-25 | 2015-10-01 | Terumo Bct, Inc. | Passive replacement of media |
| US20160090569A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled Feed |
| RU2644650C2 (ru) | 2014-12-01 | 2018-02-13 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток и способ его получения |
| US10258652B2 (en) | 2014-12-18 | 2019-04-16 | Pluristem Ltd. | Methods and compositions for treating and preventing muscle wasting disorders |
| WO2016151476A1 (en) | 2015-03-23 | 2016-09-29 | Pluristem Ltd. | Use of adherent stromal cells for enhancing hematopoiesis in a subject in need thereof |
| CA3177726A1 (en) | 2015-05-21 | 2016-11-24 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
| RU2628092C1 (ru) * | 2016-02-10 | 2017-08-14 | Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации - Институт медико-биологических проблем Российской академии наук (ГНЦ РФ - ИМБП РАН) | Способ получения МСК-ассоциированных недифференцированных гемопоэтических клеток-предшественников с фенотипов CD34+/CD133+ |
| CN109072189A (zh) * | 2016-02-12 | 2018-12-21 | 细胞治疗药物公司 | 脂肪组织衍生的间充质基质细胞条件培养基及其制备和使用方法 |
| US20210205370A1 (en) | 2016-02-18 | 2021-07-08 | Pluristem Ltd. | Methods and compositions for treating cancers and neoplasms |
| JP7034949B2 (ja) | 2016-05-25 | 2022-03-14 | テルモ ビーシーティー、インコーポレーテッド | 細胞の増殖 |
| RU2708329C2 (ru) | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
| WO2017212309A1 (en) | 2016-06-06 | 2017-12-14 | Pluristem Ltd. | Altered adherent stromal cells and methods of producing and using same |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| US20200080147A1 (en) * | 2017-02-20 | 2020-03-12 | Pluristem Ltd. | Methods and compositions for tumor assessment |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| US12234441B2 (en) | 2017-03-31 | 2025-02-25 | Terumo Bct, Inc. | Cell expansion |
| CN117247899A (zh) | 2017-03-31 | 2023-12-19 | 泰尔茂比司特公司 | 细胞扩增 |
| US11345884B2 (en) | 2017-03-31 | 2022-05-31 | Cellum Biomedical, Inc. | Biocompatible conditioned cell medium compositions and uses thereof |
| US20200246386A1 (en) | 2017-04-24 | 2020-08-06 | Pluristem Ltd. | Methods and compositions for treating neurological disorders |
| WO2018199194A1 (ja) * | 2017-04-25 | 2018-11-01 | 北海道公立大学法人札幌医科大学 | 間葉系幹細胞の製造方法、間葉系幹細胞の治療効果マーカー及び治療効果判定方法、並びに間葉系幹細胞を含む細胞製剤 |
| IL260253A (en) | 2017-07-03 | 2019-01-31 | Pluristem Ltd | Methods and compounds for removing adherent cells |
| WO2019175773A1 (en) | 2018-03-12 | 2019-09-19 | Universidade Do Porto | Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells |
| JP7353652B2 (ja) | 2018-04-25 | 2023-10-02 | 北海道公立大学法人 札幌医科大学 | 生体移植用細胞シート及びその製造方法 |
| EP4146787A4 (en) | 2020-05-08 | 2024-06-26 | Gallant Pet, Inc. | Uterine-derived regenerative cell compositions and uses thereof |
| US20240082313A1 (en) * | 2021-01-26 | 2024-03-14 | The Trustees Of Indiana University | Pharmaceutical compositions and their methods of use |
| CN112813002B (zh) * | 2021-02-07 | 2022-11-08 | 天津科技大学 | 一株耐热短乳杆菌及其后生素制剂的应用 |
| GB2619893A (en) | 2021-03-23 | 2023-12-20 | Terumo Bct Inc | Cell capture and expansion |
| US12152699B2 (en) | 2022-02-28 | 2024-11-26 | Terumo Bct, Inc. | Multiple-tube pinch valve assembly |
| USD1099116S1 (en) | 2022-09-01 | 2025-10-21 | Terumo Bct, Inc. | Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5266476A (en) | 1985-06-18 | 1993-11-30 | Yeda Research & Development Co., Ltd. | Fibrous matrix for in vitro cell cultivation |
| US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
| US5902741A (en) * | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
| US5863531A (en) | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US6326198B1 (en) | 1990-06-14 | 2001-12-04 | Regents Of The University Of Michigan | Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US6010696A (en) | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
| US5168085A (en) | 1991-05-20 | 1992-12-01 | Corning Incorporated | Multi-stage twc system |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| US5629186A (en) | 1994-04-28 | 1997-05-13 | Lockheed Martin Corporation | Porous matrix and method of its production |
| US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
| US5925567A (en) | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
| US6132463A (en) | 1995-05-19 | 2000-10-17 | Etex Corporation | Cell seeding of ceramic compositions |
| JP3781433B2 (ja) | 1995-11-16 | 2006-05-31 | ケース ウエスターン リザーブ ユニバーシティ | ヒト間葉幹細胞の試験管内軟骨形成誘導 |
| US6087129A (en) * | 1996-01-19 | 2000-07-11 | Betagene, Inc. | Recombinant expression of proteins from secretory cell lines |
| US6335195B1 (en) | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| US6291240B1 (en) * | 1998-01-29 | 2001-09-18 | Advanced Tissue Sciences, Inc. | Cells or tissues with increased protein factors and methods of making and using same |
| WO1999047922A2 (en) | 1998-03-18 | 1999-09-23 | Massachusetts Institute Of Technology | Vascularized perfused microtissue/micro-organ arrays |
| AU4336599A (en) | 1998-06-08 | 1999-12-30 | Osiris Therapeutics, Inc. | (in vitro) maintenance of hematopoietic stem cells |
| US6153432A (en) | 1999-01-29 | 2000-11-28 | Zen-Bio, Inc | Methods for the differentiation of human preadipocytes into adipocytes |
| BR0009403A (pt) | 1999-02-04 | 2001-11-27 | Technion Res & Dev Foundation | Método de expansão/conservação das células detronco hemopoiéticas indiferenciadas ou dascélulas progenitoras, método de preparação deum meio condicionado de célula estomacal útil naexpansão/conservação das células de troncohemopoiéticas indiferenciadas ou das célulasprogenitoras, método de transplante de célulasde tronco hemopoiéticas indiferenciadas ou decélulas progenitoras em um recipiente, tampão debiorreator e biorreator |
| BR0008552A (pt) * | 1999-03-10 | 2002-05-07 | Univ Pittsburgh | Células tronco e redes derivadas de tecido adiposo |
| US6372494B1 (en) * | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
| AU4860900A (en) | 1999-06-02 | 2000-12-18 | Lifebank Services, L.L.C. | Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells |
| US6555374B1 (en) | 1999-08-19 | 2003-04-29 | Artecel Sciences, Inc. | Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
| ES2300320T3 (es) | 2000-02-26 | 2008-06-16 | Artecel, Inc. | Celulas madre pluripotentes generadas a partir de celulas del estroma derivadas de tejido adiposo y sus usos. |
| US6916640B2 (en) * | 2000-10-12 | 2005-07-12 | Agency For Science, Technology And Research | Multi-layer cell encapsulation for tissue engineering |
| US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| EP2305795B1 (en) * | 2000-12-06 | 2019-07-03 | Celularity, Inc. | Method of collecting placental stem cells |
| ES2432493T3 (es) * | 2001-02-14 | 2013-12-03 | Anthrogenesis Corporation | Placenta de mamífero post-parto, su uso y células madre de la misma |
| EP2316918B1 (en) * | 2001-02-14 | 2015-07-01 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
| JP2005508393A (ja) * | 2001-11-09 | 2005-03-31 | アーテセル・サイエンシズ・インコーポレーテツド | 胚および成人幹細胞をサポートするための間質細胞の使用の方法および組成物 |
| JP2003180334A (ja) * | 2001-12-17 | 2003-07-02 | Japan Science & Technology Corp | 三次元高密度細胞培養用モジュール |
| US7504099B2 (en) | 2001-12-27 | 2009-03-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods of inducing or enhancing connective tissue repair |
| US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| US20030235563A1 (en) * | 2002-04-19 | 2003-12-25 | Strom Stephen C. | Placental derived stem cells and uses thereof |
| US20060172304A1 (en) | 2003-02-27 | 2006-08-03 | Elaine Fuchs | Method for modulating epithelial stem cell lineage |
| EP2399990B1 (en) * | 2003-06-27 | 2015-07-22 | DePuy Synthes Products, Inc. | Cells derived from post-partum umbilical cord for use in treatment of disease of the heart and circulatory system |
| US6924458B2 (en) | 2003-07-17 | 2005-08-02 | Great Computer Corp. | Auxiliary focusing tool for laser marker |
| US20050265980A1 (en) * | 2004-05-14 | 2005-12-01 | Becton, Dickinson And Company | Cell culture environments for the serum-free expansion of mesenchymal stem cells |
| DE102004043256B4 (de) * | 2004-09-07 | 2013-09-19 | Rheinische Friedrich-Wilhelms-Universität Bonn | Skalierbarer Prozess zur Kultivierung undifferenzierter Stammzellen in Suspension |
| CN103361301A (zh) | 2005-03-31 | 2013-10-23 | 斯丹姆涅恩有限公司 | 高度纯化来自羊膜的细胞群 |
| WO2007091255A2 (en) * | 2006-02-06 | 2007-08-16 | Pluristem Ltd. | Method and apparatus for maintenance and expansion of hematopoietic stem cells from mononuclear cells |
| EP2548951B1 (en) * | 2006-03-23 | 2016-05-04 | Pluristem Ltd. | Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
| KR101903339B1 (ko) * | 2011-03-22 | 2018-10-01 | 플루리스템 리미티드 | 방사선 또는 화학적 손상을 치료하는 방법 |
-
2007
- 2007-03-22 EP EP12189046.1A patent/EP2548951B1/en active Active
- 2007-03-22 DK DK11170055.5T patent/DK2366775T3/en active
- 2007-03-22 ES ES11170055.5T patent/ES2537641T3/es active Active
- 2007-03-22 US US12/225,478 patent/US20110129447A1/en not_active Abandoned
- 2007-03-22 HU HUE12189046A patent/HUE028796T2/en unknown
- 2007-03-22 EP EP07713395A patent/EP2010647A4/en not_active Withdrawn
- 2007-03-22 KR KR1020147029038A patent/KR101557256B1/ko active Active
- 2007-03-22 PT PT111700555T patent/PT2366775E/pt unknown
- 2007-03-22 PT PT131643033T patent/PT2626417E/pt unknown
- 2007-03-22 SI SI200731782A patent/SI2548951T1/sl unknown
- 2007-03-22 BR BRPI0709349-7A patent/BRPI0709349A2/pt not_active Application Discontinuation
- 2007-03-22 JP JP2009502327A patent/JP5733894B2/ja active Active
- 2007-03-22 PL PL12189046T patent/PL2548951T3/pl unknown
- 2007-03-22 PL PL11170055T patent/PL2366775T3/pl unknown
- 2007-03-22 MX MX2008012085A patent/MX2008012085A/es active IP Right Grant
- 2007-03-22 PT PT121890461T patent/PT2548951E/pt unknown
- 2007-03-22 EP EP13164303.3A patent/EP2626417B1/en active Active
- 2007-03-22 EP EP16157193.0A patent/EP3091071B1/en not_active Revoked
- 2007-03-22 WO PCT/IL2007/000380 patent/WO2007108003A2/en not_active Ceased
- 2007-03-22 RU RU2008141894/10A patent/RU2433177C2/ru active
- 2007-03-22 CA CA2646384A patent/CA2646384C/en active Active
- 2007-03-22 CN CN201510738761.1A patent/CN105296415A/zh active Pending
- 2007-03-22 ES ES13164303.3T patent/ES2549528T3/es active Active
- 2007-03-22 ES ES12189046T patent/ES2572214T3/es active Active
- 2007-03-22 SG SG201102089-8A patent/SG170761A1/en unknown
- 2007-03-22 DK DK13164303.3T patent/DK2626417T3/en active
- 2007-03-22 KR KR1020087025460A patent/KR101490449B1/ko active Active
- 2007-03-22 EP EP20110170055 patent/EP2366775B1/en active Active
- 2007-03-22 AU AU2007228341A patent/AU2007228341B2/en active Active
-
2011
- 2011-06-16 JP JP2011133774A patent/JP5766041B2/ja active Active
-
2013
- 2013-12-20 JP JP2013263148A patent/JP5941454B2/ja active Active
-
2014
- 2014-12-11 IL IL236213A patent/IL236213A/en active IP Right Grant
-
2015
- 2015-10-01 US US14/873,092 patent/US20160022738A1/en not_active Abandoned
-
2016
- 2016-05-12 HK HK16105449.8A patent/HK1217513A1/zh unknown
- 2016-05-19 HR HRP20160538TT patent/HRP20160538T1/hr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009531059A5 (https=) | ||
| RU2008141894A (ru) | Способы экспансии клеток и применение клеток и кондиционных сред, полученных таким образом, для лечения | |
| JP2011529706A5 (https=) | ||
| WO2010106436A3 (en) | Novel anti-inflammatory agents | |
| TW200608995A (en) | Antagonizing interleukin-21 receptor activity | |
| HRP20201487T1 (hr) | Stvaranje banke stanica strome mezenhima iz mononuklearnih stanica prikupljenih iz više donora koštane srži | |
| JP2014508527A5 (https=) | ||
| Sun et al. | Human umbilical cord blood-derived stromal cells are superior to human umbilical cord blood-derived mesenchymal stem cells in inducing myeloid lineage differentiation in vitro | |
| EP2258833A3 (en) | Isolation of a new cardiac stem cell population | |
| Ogawa et al. | Hematopoietic stem cell origin of mesenchymal cells: opportunity for novel therapeutic approaches | |
| IL194232A (en) | Methods for proliferation of cells, cells, and tumor fluids produced through them, and drugs containing them | |
| Tyndall et al. | Mesenchymal stem cells for multiple sclerosis: can we find the answer? | |
| Shachpazyan et al. | Systems approach to the guarantee of quality of mesenchymal stem cells of bone marrow for the clinical use | |
| Antonijević et al. | The role of mesenchymal stem cells in the therapy of myocardial infarction | |
| Miyagi et al. | MACROPHAGES IN THE DEGENERATED INTERVERTEBRAL DISC PRODUCE INFLAMMATORY CYTOKINES, BUT NOT GROWTH FACTORS, IN A MOUSE MODEL OF DISC INJURY: P48 | |
| Sadeghi et al. | The Effects of Deferoxamine on the Up regulation of Chemokine Receptor 2 in Bone Marrow Stromal Stem Cells | |
| Zielins et al. | Heterogeneity of Progenitor Cell Populations and their Therapeutic Implications | |
| EY | Systems approach to the guarantee of quality of mesenchymal stem cells of bone marrow for the clinical use | |
| Srivastava | Deepak Srivastava Human adult somatic cells can be reprogrammed to induced pluripotent stem (iPS) cells upon the introduction of four transcription factors that are part of the pluripotency network in embryonic stem cells. The ability to readily from patients with disease has ushered in new opportunities to understand disease mechanisms | |
| Guo | Some problematic issues about mesenchymal stem cells and their clinical application | |
| HK1160174B (en) | Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy | |
| HK1136846B (en) | Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |